- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Ophthalmology and Telehealth, A Suitable Match | AAO 2023
Albert S. Khouri, M.D., says ophthalmic care lends itself to telehealth because it is image based. As with many other areas of medicine, the COVID-19 pandemic accelerated adoption.
Telehealth swept through healthcare during the early peak days of the COVID-19 epidemic, and ophthalomology was not exception.
But Albert S. Khouri, a professor of ophthalmology at the Rutgers New Jersey Medical School, says that ophthalmic care is particularly well suited to delivery via telehealth.
“A lot of the technologies that we use are image-based and are very objective, meaning there’s data generated during the encounter that lend the technology well to telemedicine,” Khouri said in an interview with Managed Healthcare Executive.
Khouri was one of the seven instructors for an educational session on innovations in teleophthalmology on Saturday at the annual meeting of the American Academy of Ophthalmology meeting in San Francisco. The other instructors were April Y Maa, M.D., Andrew G. Lee, M.D., Roomasa Channa, M.D., David J. Ramsey, M.D., and Lama A. Al-Aswad, M.D., M.P.H. The senior instructor was Gary L. Legault, M.D.
PHOTON Study of 8-mg Eylea Suggests Some Patients Could Be Treated Just Two Times a Year | AAO 2023
November 5th 2023Approximately one-third of the patients assigned to 16-week intervals of 8-mg formulation of Eylea changed to a 24-week interval during the second year of. the study, according results presented at the annual meeting of the American Academy of Ophthalmology. The PHOTON study enrolled people with diabetic macular edema.
Read More
Teleophthalmology: One Way To Help Span the Healthcare Disparity Divide | AAO 2023
November 5th 2023Albert S. Khouri, M.D., a professor of ophthalmology at the Rutgers New Jersey Medical School, discusses teleophthalmology’s role in outreach efforts and improving ophthalmic care in the emergency room.
Read More
